• Founded Patoximed Consultants in 1995 after over 15 years experience in preclinical toxicologic evaluation and in investigative research projects related to development and discovery of novel drugs at G.D. Searle & Co. and at Hoffmann-LaRoche Inc.
  
  
• At Searle and Roche, served as director of general pathology; study pathologist; study director; principal investigator/collaborator; reviewer of drug resumes; author of toxicology summaries; presenter of toxicology-pathology data at the FDA; member of R&D project teams, various committees and task forces.
  
  
• Member of national and international professional societies for pathology, toxicology, pharmacology, laboratory animals, tissue culture, experimental biology and medicine.
  
  
• Editorial-board member, J. Toxicol. Environ. Health and Exp. Biol. Med. (Pharmacology/Toxicology); Ad-hoc reviewer of manuscripts for several professional journals and book chapters; chair/co-chair of pathology nomenclature committees and toxicology symposia.
  
  
• Program director, Northeast Division of the Charles Louis Davis, D.V.M. Foundation for international advancement in veterinary and comparative pathology, and member of the Board of Directors and faculty of the Foundation; adjunct faculty, The Rockefeller University, New York; visiting assistant-professor of Pathology, Rush Medical College, Chicago.
   
• DIPLOMATE, American College of Veterinary Pathologists and the American Board of Toxicology.
   
• EDUCATION: B.S. (Zoology, 1969), Doctor of Veterinary Medicine (1972), M.S. (Veterinary Pathology, 1973) Iowa State University; A.M. (Experimental Pathology, 1975) Harvard University; Ph.D. (Pathobiology, 1980) University of Connecticut.